{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:11:15Z","timestamp":1769015475548,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["407192\/2018-2"],"award-info":[{"award-number":["407192\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["408789\/2016\\u20136"],"award-info":[{"award-number":["408789\/2016\\u20136"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["151206-2024-4"],"award-info":[{"award-number":["151206-2024-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Foundation for Support of Science and Technology of Pernambuco State","doi-asserted-by":"publisher","award":["APQ-1324-2.08\/22"],"award-info":[{"award-number":["APQ-1324-2.08\/22"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Foundation for Support of Science and Technology of Pernambuco State","doi-asserted-by":"publisher","award":["IBPG-0422-5.05\/20"],"award-info":[{"award-number":["IBPG-0422-5.05\/20"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Foundation for Support of Science and Technology of Pernambuco State","doi-asserted-by":"publisher","award":["APQ-0108-2.08-14"],"award-info":[{"award-number":["APQ-0108-2.08-14"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.micpath.2025.107687","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:03:23Z","timestamp":1746792203000},"page":"107687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advances in COVID-19 Therapeutics: Exploring the role of lectins and protease inhibitors"],"prefix":"10.1016","volume":"205","author":[{"given":"Lucas Gabriel","family":"Pita dos Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"da Silva Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia Maria","family":"Rodrigues Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Miranda da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Francisco da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Paulo","family":"Marcelino Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beto Cherles","family":"Coral Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Welton","family":"Aaron de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardilles Juan","family":"Carlos Alves dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago Henrique","family":"Napole\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-3650","authenticated-orcid":false,"given":"Emmanuel Viana","family":"Pontual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.micpath.2025.107687_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.24171\/j.phrp.2020.11.3.08","article-title":"COVID-19 outbreak in Malaysia. Osong public","volume":"11","author":"Elengoe","year":"2020","journal-title":"Health. Res. Perspect."},{"key":"10.1016\/j.micpath.2025.107687_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.micpath.2025.107687_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.micpath.2025.107687_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.micpath.2025.107687_bib6","first-page":"268","article-title":"Epidemiology and clinical characteristics of COVID-19. Arch. Iran","volume":"23","author":"Huang","year":"2020","journal-title":"Med."},{"issue":"5","key":"10.1016\/j.micpath.2025.107687_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.otorri.2022.11.001","article-title":"Sinonasal mucormycosis during 2 Years of COVID-19 pandemic in Central Iran: incidence rate and clinical features","volume":"74","author":"Dadgarnia","year":"2023","journal-title":"Acta Otorrinolaringol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107687_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal Co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.micpath.2025.107687_bib9","article-title":"Informa\u00e7\u00f5es sobre O novo coronav\u00edrus (COVID-19)","volume":"53","author":"Lima","year":"2020","journal-title":"Radiol. Bras."},{"issue":"10","key":"10.1016\/j.micpath.2025.107687_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.medcli.2021.05.014","article-title":"Clinical features and prognosis of COVID-19 patients with metabolic syndrome: a multicenter, retrospective study","volume":"158","author":"Wang","year":"2022","journal-title":"Med. Clin."},{"key":"10.1016\/j.micpath.2025.107687_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.34024\/rnc.2021.v29.11842","article-title":"Achados Neuropatol\u00f3gicos Da Covid-19: Uma Revis\u00e3o Sistem\u00e1tica","volume":"29","author":"Ferreira","year":"2021","journal-title":"Revista Neuroci\u00eancias"},{"issue":"7","key":"10.1016\/j.micpath.2025.107687_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18089","article-title":"Biomedical equipments, vaccine and drug in the prevention, diagnosis and treatment of COVID-19","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"issue":"25","key":"10.1016\/j.micpath.2025.107687_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.9734\/jpri\/2020\/v32i2530824","article-title":"Cytokine storm, corticosteroids and interleukin-6 receptor antibodies in context of antiinflammatory treatment in COVID-19","volume":"32","author":"Karcioglu","year":"2020","journal-title":"J. Pharm. Res. Int."},{"issue":"12","key":"10.1016\/j.micpath.2025.107687_bib14","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3390\/vaccines10122145","article-title":"SARS-CoV-2: an updated review highlighting its evolution and treatments","volume":"10","author":"Zhang","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.micpath.2025.107687_bib15","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/jmv.26698","article-title":"Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection","volume":"93","author":"Hariyanto","year":"2021","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107687_bib16","doi-asserted-by":"crossref","first-page":"P19","DOI":"10.1164\/rccm.2020C1","article-title":"Diagnosis and management of COVID-19 disease","volume":"201","author":"Jamil","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"50","key":"10.1016\/j.micpath.2025.107687_bib17","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1016\/j.vaccine.2020.10.056","article-title":"India's cost-effective COVID-19 vaccine development initiatives","volume":"38","author":"Chakraborty","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.micpath.2025.107687_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4155\/tde-2020-0129","article-title":"An overview of vaccine development for COVID-19","volume":"12","author":"Shahcheraghi","year":"2021","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.micpath.2025.107687_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109175","article-title":"Recent advances in the vaccine development for the prophylaxis of SARS covid-19","volume":"111","author":"Kumar","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib20","first-page":"221","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting wuhan. Emerg. Microbes","volume":"9","author":"Chan","year":"2020","journal-title":"Infect."},{"issue":"2","key":"10.1016\/j.micpath.2025.107687_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40475-020-00201-6","article-title":"The SARS-CoV-2 vaccine Pipeline: an overview","volume":"7","author":"Chen","year":"2020","journal-title":"Curr. Trop. Med. Rep"},{"issue":"5","key":"10.1016\/j.micpath.2025.107687_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.22159\/ajpcr.2021.v14i5.41061","article-title":"Current updates on CoVID-19 vaccines","volume":"14","author":"Misra","year":"2021","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"issue":"12","key":"10.1016\/j.micpath.2025.107687_bib23","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/erv.12.126","article-title":"Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome","volume":"11","author":"Jiang","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2025.107687_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41562-020-0928-4","article-title":"Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil","volume":"4","author":"Souza","year":"2020","journal-title":"Nat. Hum. Behav."},{"issue":"5","key":"10.1016\/j.micpath.2025.107687_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.11606\/issn.1679-9836.v99i5p473-479","article-title":"SARS-CoV-2: taxonomia, origem E constitui\u00e7\u00e3o","volume":"99","author":"Khalil","year":"2020","journal-title":"Revista de Medicina"},{"key":"10.1016\/j.micpath.2025.107687_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.micpath.2025.107687_bib27","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.micpath.2025.107687_bib28","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2213-2600(20)30224-1","article-title":"SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors","volume":"8","author":"Milne","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.micpath.2025.107687_bib29","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1002\/jmv.26791","article-title":"Mutations in SARS\u2010CoV\u20102 Nsp7 and Nsp8 proteins and their predicted impact on replication\/transcription complex structure","volume":"93","author":"Reshamwala","year":"2021","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib30","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1038\/s41598-023-35907-w","article-title":"Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and Nsp14 guanine N7-methyltransferase","volume":"13","author":"Zmudzinski","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.micpath.2025.107687_bib31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jiph.2023.09.020","article-title":"Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: the study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses","volume":"6","author":"Chakraborty","year":"2023","journal-title":"J. Infect. Public Health"},{"issue":"3","key":"10.1016\/j.micpath.2025.107687_bib32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.virs.2023.04.008","article-title":"Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase","volume":"38","author":"Zhang","year":"2023","journal-title":"Virol. Sin."},{"issue":"7837","key":"10.1016\/j.micpath.2025.107687_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"Benton","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.micpath.2025.107687_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.micpath.2025.107687_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/md18110543","article-title":"Man-specific, GalNAc\/T\/Tn-Specific and Neu5Ac-specific seaweed lectins as glycan probes for the SARS-CoV-2 (COVID-19) coronavirus","volume":"18","author":"Barre","year":"2020","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s11658-022-00338-4","article-title":"Lectins and lectibodies: potential promising antiviral agents","volume":"27","author":"Nabi-Afjadi","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"8","key":"10.1016\/j.micpath.2025.107687_bib37","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/bit.28122","article-title":"Marine biological macromolecules as matrix material for biosensor fabrication","volume":"119","author":"Bedi","year":"2022","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/22221751.2021.1957720","article-title":"Lentil lectin derived from lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants","volume":"10","author":"Wang","year":"2021","journal-title":"Emerg. Microb. Infect."},{"issue":"4","key":"10.1016\/j.micpath.2025.107687_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/act.2020.29286.klu","article-title":"Dietary lectins: gastrointestinal and immune effects","volume":"26","author":"Lucius","year":"2020","journal-title":"Alternative Compl. Ther."},{"issue":"5","key":"10.1016\/j.micpath.2025.107687_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/antibiotics10050520","article-title":"Potential application of combined therapy with lectins as a therapeutic strategy for the treatment of bacterial infections","volume":"10","author":"Santos","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7251346","article-title":"Preparation and nanoencapsulation of lectin from lepidium sativum on chitosan-tripolyphosphate nanoparticle and their cytotoxicity against hepatocellular carcinoma cells (HepG2)","volume":"2020","author":"Yasin","year":"2020","journal-title":"BioMed Res. Int."},{"issue":"16","key":"10.1016\/j.micpath.2025.107687_bib42","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.3390\/ijms22168637","article-title":"What molecular recognition systems do mesenchymal stem cells\/medicinal signaling cells (MSC) use to facilitate cell-cell and cell matrix interactions? A review of evidence and options","volume":"22","author":"Hart","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2025.107687_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101719","article-title":"Lectin\u2010functionalized polyethylene glycol for relief of mucosal dryness","volume":"11","author":"Blakeley","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.micpath.2025.107687_bib44","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4324-2021200631","article-title":"Antibacterial activity of plant lectins: a review","volume":"64","author":"Silva","year":"2021","journal-title":"Braz. Arch. Biol. Technol."},{"key":"10.1016\/j.micpath.2025.107687_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.algal.2022.102962","article-title":"Antitumor lectins from algae: a systematic review","volume":"70","author":"Arruda","year":"2023","journal-title":"Algal Res."},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib46","first-page":"1","article-title":"Antiviral lectins of the plant family Ama","volume":"34","author":"Nair","year":"2024","journal-title":"ryllidaceae. Revista Brasileira de Farmacognosia"},{"key":"10.1016\/j.micpath.2025.107687_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijbiomac.2020.04.125","article-title":"Antiviral activity of native banana lectin against bovine viral diarrhea virus and bovine alphaherpesvirus type 1","volume":"157","author":"Camargo","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107687_bib48","doi-asserted-by":"crossref","DOI":"10.55251\/jmbfs.4224","article-title":"Applications of plant lectins in biotechnology and therapeutics","volume":"11","author":"Naik","year":"2022","journal-title":"J. Microbiol. Biotechnol. Food Sci."},{"key":"10.1016\/j.micpath.2025.107687_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112507","article-title":"Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies","volume":"146","author":"Ahmed","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2025.107687_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133664","article-title":"Lectins in oncology and virology: mechanisms of anticancer activity and SARS-CoV-2 inhibition","volume":"275","author":"Boliukh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2025.107687_bib51","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.3390\/ijms221910205","article-title":"Lectin from Triticum vulgaris (WGA) inhibits infection with SARS-CoV-2 and its variants of concern alpha and Beta","volume":"22","author":"Auth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.micpath.2025.107687_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214561120","article-title":"Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2","volume":"120","author":"Mu\u00f1oz-Basagoiti","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.micpath.2025.107687_bib53","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.3390\/ijms25126696","article-title":"Microcystis viridis NIES-102 cyanobacteria lectin (MVL) interacts with SARS-CoV-2 spike protein receptor binding domains (RBDs) via protein\u2013protein interaction","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107687_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105856","article-title":"Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A","volume":"225","author":"Klevanski","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107687_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2023.109116","article-title":"Application of concanavalin A as a new diagnostic strategy for SARS-COV-2 spike protein","volume":"201","author":"Lucena","year":"2024","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.micpath.2025.107687_bib56","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/v16101546","article-title":"Identification of a novel antiviral lectin against SARS-CoV-2 Omicron variant from shiitake-mushroom-derived vesicle-like nanoparticles","volume":"16","author":"Wiggins","year":"2024","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.micpath.2025.107687_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101486","article-title":"C-type lectins link immunological and reproductive processes in Aedes aegypti","volume":"23","author":"Li","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.micpath.2025.107687_bib58","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ijbiomac.2019.10.180","article-title":"Mushroom lectins in biomedical research and development","volume":"151","author":"Singh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib59","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.2174\/1381612827666210830094743","article-title":"The use of lectins as tools to combat SARS-CoV-2","volume":"27","author":"Martinez","year":"2021","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.micpath.2025.107687_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2022.103301","article-title":"Plant lectins as potent anti-coronaviruses, anti-inflammatory, antinociceptive and antiulcer agents","volume":"29","author":"Konozy","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.107687_bib61","first-page":"17","article-title":"High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors","volume":"14","author":"Zang","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.micpath.2025.107687_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105606","article-title":"Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2","volume":"214","author":"Li","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2025.107687_bib63","doi-asserted-by":"crossref","first-page":"114614","DOI":"10.1016\/j.biopha.2023.114614","article-title":"FDA approved drugs with antiviral activity against SARS-CoV-2: from structure-based repurposing to host-specific mechanisms","volume":"162","author":"Ahmed","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.micpath.2025.107687_bib64","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.micpath.2025.107687_bib65","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41589-022-01059-7","article-title":"Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation","volume":"18","author":"Fraser","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"6497","key":"10.1016\/j.micpath.2025.107687_bib66","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"issue":"6575","key":"10.1016\/j.micpath.2025.107687_bib67","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.micpath.2025.107687_bib69","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1002\/jcp.30367","article-title":"Higher infectivity of the SARS\u2010CoV\u20102 new variants is associated with K417N\/T, E484K, and N501Ymutants: aninsight from structural data","volume":"236","author":"Khan","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.micpath.2025.107687_bib70","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/v14092075","article-title":"Structural basis for the inhibition of coronaviral main proteases by a benzothiazole-based inhibitor","volume":"14","author":"Hu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107687_bib71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","article-title":"A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic","volume":"605","author":"Shapira","year":"2022","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.micpath.2025.107687_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012522","article-title":"Reactive centre loop mutagenesis of SerpinB3 to target TMPRSS2 and furin: inhibition of SARS-CoV-2 cell entry and replication","volume":"23","author":"Singh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.micpath.2025.107687_bib73","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.3390\/ijms24108633","article-title":"Structure-based design of potent peptidomimetic inhibitors covalently targeting SARS-CoV-2 papain-like protease","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2025.107687_bib74","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/ptr.7008","article-title":"Botanical drugs and supplements affecting the immune response in the time of COVID \u201019: implications for research and clinical practice","volume":"35","author":"Brendler","year":"2020","journal-title":"Phytother Res."},{"issue":"6","key":"10.1016\/j.micpath.2025.107687_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102155","article-title":"Exploring the phytochemicals of platycodon grandiflorus for TMPRSS2 inhibition in the search for SARS-CoV-2 entry inhibitors","volume":"34","author":"Gurung","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"issue":"5","key":"10.1016\/j.micpath.2025.107687_bib76","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/ijms23052643","article-title":"Molecular interactions of tannic acid with proteins associated with SARS-CoV-2 infectivity","volume":"23","author":"Haddad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107687_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.02.012","article-title":"Epigallocatechin-3-Gallate, an active ingredient of traditional Chinese medicines, inhibits the 3CLpro activity of SARS-CoV-2","volume":"176","author":"Du","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2025.107687_bib78","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.adm9724","article-title":"Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model","volume":"383","author":"Tan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.micpath.2025.107687_bib79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11418-024-01874-3","article-title":"Potent SARS-CoV-2 3C-like protease inhibitor (+)-eupenoxide-3,6-diketone (IC50: 0.048 \u03bcM) was synthesized based on (+)-eupenoxide; lead from (+)-eupenoxide analogs study by endophytic fermentation","volume":"79","author":"Maehara","year":"2025","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.micpath.2025.107687_bib80","article-title":"Discovery of the clinical candidate S-892216: a second-generation of SARS-CoV-2 3CL protease inhibitor for treating COVID-19","volume":"2025\u201302","author":"Unoh","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.micpath.2025.107687_bib81","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41467-024-55421-5","article-title":"Development of small molecule noncovalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107687_bib82","article-title":"Single- and multiple-dose pharmacokinetics and safety of the SARS-CoV-2 3CL protease inhibitor RAY1216: a phase 1 study in healthy participants","volume":"e01450\u201324","author":"Hu","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107687_bib83","series-title":"COVID-19 Epidemiological Update \u2013 Edition 159","year":"2023"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025004127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025004127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T02:36:57Z","timestamp":1749177417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025004127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":81,"alternative-id":["S0882401025004127"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107687","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in COVID-19 Therapeutics: Exploring the role of lectins and protease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107687"}}